News

New targeted treatments are major advances for HER2-positive breast cancer
- Author:
- Alan P. Lyss, MD
Dr. Alan Lyss reviews data on HER2-targeted therapies in breast cancer.
Article

The power and promise of social media in oncology
- Author:
- Alan P. Lyss, MD
Dr. Alan Lyss describes a recent presentation on the role of social media in oncology.
Article

IMvigor130: A treasure trove of data for urothelial carcinoma
- Author:
- Alan P. Lyss, MD
Dr. Alan Lyss reviews updated results with atezolizumab in locally advanced or metastatic urothelial carcinoma.
Article

Leveraging the microbiome to enhance cancer treatment
- Author:
- Alan P. Lyss, MD
Dr. Alan Lyss reviews research suggesting that an antibiotic can improve the efficacy of radiotherapy.
Article

Steroid-refractory pneumonitis from ICIs: Experience at major centers
- Author:
- Alan P. Lyss, MD
Dr. Alan Lyss explores two studies of patients with steroid-resistant or refractory pneumonitis resulting from...
Article

mCODE: Improving data sharing to enhance cancer care
- Author:
- Alan P. Lyss, MD
Dr. Alan Lyss explores mCODE, a project designed to improve the sharing of data from cancer patients.
Article

Genetic testing for breast and ovarian cancer: What has changed and what still needs to change?
- Author:
- Alan P. Lyss, MD
Dr. Alan Lyss reviews a study that revealed trends in genetic testing over time.
Opinion

Enfortumab vedotin offers hope to poor-prognosis patients with advanced urothelial cancer
- Author:
- Alan P. Lyss, MD
EV is an antibody-drug conjugate directed against nectin-4, an immunoglobulin-like cell adhesion molecule that...
Article

How has the pandemic affected rural and urban cancer patients?
- Author:
- Alan P. Lyss, MD
A survey suggests the pandemic has impacted rural and urban cancer patients somewhat differently.
Article

X-ray vision: Using AI to maximize the value of radiographic images
- Author:
- Alan P. Lyss, MD
Dr. Alan Lyss reviews studies using artificial intelligence to predict lung cancer risk and outcomes.
Article

ctDNA outperforms CEA in colorectal cancer
- Author:
- Alan P. Lyss, MD
Circulating tumor DNA testing bested carcinoembryonic antigen testing in a study of patients with colorectal...
Article

RSClin: A new tool for ‘TAILOR-ing’ treatment in early breast cancer
- Author:
- Alan P. Lyss, MD
Dr. Alan P. Lyss describes RSClin, a tool for estimating the risk of distant relapse in breast cancer. ...
Article

DART trial hits the target in angiosarcoma
- Author:
- Alan P. Lyss, MD
Dr. Alan Lyss reviews results of the DART trial and highlights the value of clinical trials for rare cancers....
Article

How should we evaluate the benefit of immunotherapy combinations?
- Author:
- Alan P. Lyss, MD
Dr. Alan Lyss examines how new endpoints, novel study design, and other methods might better quantify the...
Article

Using telehealth to deliver palliative care to cancer patients
- Author:
- Alan P. Lyss, MD
Dr. Alan Lyss discusses the use of telehealth for palliative cancer care, including results from the REACH PC trial.